575 related articles for article (PubMed ID: 29861833)
1. Flavonoids as Therapeutic Agents in Alzheimer's and Parkinson's Diseases: A Systematic Review of Preclinical Evidences.
de Andrade Teles RB; Diniz TC; Costa Pinto TC; de Oliveira Júnior RG; Gama E Silva M; de Lavor ÉM; Fernandes AWC; de Oliveira AP; de Almeida Ribeiro FPR; da Silva AAM; Cavalcante TCF; Quintans Júnior LJ; da Silva Almeida JRG
Oxid Med Cell Longev; 2018; 2018():7043213. PubMed ID: 29861833
[TBL] [Abstract][Full Text] [Related]
2. New therapeutic strategy for Parkinson's and Alzheimer's disease.
Esposito E; Cuzzocrea S
Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
[TBL] [Abstract][Full Text] [Related]
3. The use of flavonoids in central nervous system disorders.
Grosso C; Valentão P; Ferreres F; Andrade PB
Curr Med Chem; 2013; 20(37):4694-719. PubMed ID: 23834189
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.
Beal MF
J Bioenerg Biomembr; 2004 Aug; 36(4):381-6. PubMed ID: 15377876
[TBL] [Abstract][Full Text] [Related]
5. Computational Studies Applied to Flavonoids against Alzheimer's and Parkinson's Diseases.
Monteiro AFM; Viana JO; Nayarisseri A; Zondegoumba EN; Mendonça Junior FJB; Scotti MT; Scotti L
Oxid Med Cell Longev; 2018; 2018():7912765. PubMed ID: 30693065
[TBL] [Abstract][Full Text] [Related]
6. Target-based selection of flavonoids for neurodegenerative disorders.
Jones QR; Warford J; Rupasinghe HP; Robertson GS
Trends Pharmacol Sci; 2012 Nov; 33(11):602-10. PubMed ID: 22980637
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease.
Braidy N; Behzad S; Habtemariam S; Ahmed T; Daglia M; Nabavi SM; Sobarzo-Sanchez E; Nabavi SF
CNS Neurol Disord Drug Targets; 2017; 16(4):387-397. PubMed ID: 28474543
[TBL] [Abstract][Full Text] [Related]
8. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
[TBL] [Abstract][Full Text] [Related]
9. Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms.
Haddadi R; Shahidi Z; Eyvari-Brooshghalan S
Phytomedicine; 2020 Dec; 79():153320. PubMed ID: 32920285
[TBL] [Abstract][Full Text] [Related]
10. Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer's Disease and Parkinson's Disease.
Nakajima A; Ohizumi Y
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295812
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease.
Jiang T; Sun Q; Chen S
Prog Neurobiol; 2016 Dec; 147():1-19. PubMed ID: 27769868
[TBL] [Abstract][Full Text] [Related]
12. The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review.
Manoharan S; Guillemin GJ; Abiramasundari RS; Essa MM; Akbar M; Akbar MD
Oxid Med Cell Longev; 2016; 2016():8590578. PubMed ID: 28116038
[TBL] [Abstract][Full Text] [Related]
13. Flavonoids, the Family of Plant-Derived Antioxidants Making Inroads into Novel Therapeutic Design Against Ionizing Radiation-Induced Oxidative Stress in Parkinson's Disease.
Behl T; Kaur G; Sehgal A; Zengin G; Singh S; Ahmadi A; Bungau S
Curr Neuropharmacol; 2022; 20(2):324-343. PubMed ID: 34030619
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress and neurodegenerative diseases: looking for a therapeutic solution inspired on benzopyran chemistry.
Gaspar A; Milhazes N; Santana L; Uriarte E; Borges F; Matos MJ
Curr Top Med Chem; 2015; 15(5):432-45. PubMed ID: 25658803
[TBL] [Abstract][Full Text] [Related]
15. Protective Mechanisms of Flavonoids in Parkinson's Disease.
Magalingam KB; Radhakrishnan AK; Haleagrahara N
Oxid Med Cell Longev; 2015; 2015():314560. PubMed ID: 26576219
[TBL] [Abstract][Full Text] [Related]
16. The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases.
Maher P
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234550
[TBL] [Abstract][Full Text] [Related]
17. Role of zinc and copper ions in the pathogenetic mechanisms of Alzheimer's and Parkinson's diseases.
Stelmashook EV; Isaev NK; Genrikhs EE; Amelkina GA; Khaspekov LG; Skrebitsky VG; Illarioshkin SN
Biochemistry (Mosc); 2014 May; 79(5):391-6. PubMed ID: 24954589
[TBL] [Abstract][Full Text] [Related]
18. Role of Plant-Derived Flavonoids and Their Mechanism in Attenuation of Alzheimer's and Parkinson's Diseases: An Update of Recent Data.
Hussain G; Zhang L; Rasul A; Anwar H; Sohail MU; Razzaq A; Aziz N; Shabbir A; Ali M; Sun T
Molecules; 2018 Apr; 23(4):. PubMed ID: 29614843
[TBL] [Abstract][Full Text] [Related]
19. Mangiferin: A multipotent natural product preventing neurodegeneration in Alzheimer's and Parkinson's disease models.
Feng ST; Wang ZZ; Yuan YH; Sun HM; Chen NH; Zhang Y
Pharmacol Res; 2019 Aug; 146():104336. PubMed ID: 31271846
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease.
Li Y; Zhao J; Hölscher C
CNS Drugs; 2017 Aug; 31(8):639-652. PubMed ID: 28634902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
